Skip to main content

Efficacy and tolerability of treatments for chronic cough: a systematic review and meta-analysis.

Publication ,  Journal Article
Yancy, WS; McCrory, DC; Coeytaux, RR; Schmit, KM; Kemper, AR; Goode, A; Hasselblad, V; Heidenfelder, BL; Sanders, GD
Published in: Chest
December 2013

BACKGROUND: Understanding the comparative effectiveness of treatments for patients with unexplained or refractory cough is important to increase awareness of proven therapies and their potential adverse effects in this unique population. METHODS: We performed a literature search for English-language studies published up to June 2012 that compared symptomatic therapies for chronic cough. Two investigators screened each abstract and full-text article for inclusion, abstracted data, and rated quality. Meta-analysis with random-effects models was used to summarize effects of treatments. RESULTS: We identified 49 studies (3,067 patients) comprising 68 therapeutic comparisons. Of the studied agents, opioid and certain nonopioid and nonanesthetic antitussives had demonstrated efficacy for chronic cough in adults. Compared with placebo, effect sizes (standardized mean differences for cough severity and rate ratios for cough frequency) for opioids were 0.55 (95% CI, 0.38-0.72; P < .0001) and 0.57 (95% CI, 0.36-0.91; P = .0260), respectively. For dextromethorphan, effect sizes were 0.37 (95% CI, 0.19-0.56; P = .0008) and 0.40 (95% CI, 0.18-0.85; P = .0248), respectively. The overall strength of evidence was limited by inconsistency and imprecision of results and by small numbers of direct comparisons. Nonpharmacologic therapies and the management of cough in children were infrequently studied. CONCLUSIONS: Although evidence is limited, opioid and certain nonopioid and nonanesthetic antitussives demonstrated efficacy for treating chronic cough in adults. There is a need for further studies in patients with unexplained or refractory cough as well as for more systematic study designs, assessment of patient-centered outcomes, and reporting.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Chest

DOI

EISSN

1931-3543

Publication Date

December 2013

Volume

144

Issue

6

Start / End Page

1827 / 1838

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Severity of Illness Index
  • Respiratory System
  • Outcome Assessment, Health Care
  • Humans
  • Cough
  • Chronic Disease
  • Antitussive Agents
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Yancy, W. S., McCrory, D. C., Coeytaux, R. R., Schmit, K. M., Kemper, A. R., Goode, A., … Sanders, G. D. (2013). Efficacy and tolerability of treatments for chronic cough: a systematic review and meta-analysis. Chest, 144(6), 1827–1838. https://doi.org/10.1378/chest.13-0490
Yancy, William S., Douglas C. McCrory, Remy R. Coeytaux, Kristine M. Schmit, Alex R. Kemper, Adam Goode, Victor Hasselblad, Brooke L. Heidenfelder, and Gillian D. Sanders. “Efficacy and tolerability of treatments for chronic cough: a systematic review and meta-analysis.Chest 144, no. 6 (December 2013): 1827–38. https://doi.org/10.1378/chest.13-0490.
Yancy WS, McCrory DC, Coeytaux RR, Schmit KM, Kemper AR, Goode A, et al. Efficacy and tolerability of treatments for chronic cough: a systematic review and meta-analysis. Chest. 2013 Dec;144(6):1827–38.
Yancy, William S., et al. “Efficacy and tolerability of treatments for chronic cough: a systematic review and meta-analysis.Chest, vol. 144, no. 6, Dec. 2013, pp. 1827–38. Pubmed, doi:10.1378/chest.13-0490.
Yancy WS, McCrory DC, Coeytaux RR, Schmit KM, Kemper AR, Goode A, Hasselblad V, Heidenfelder BL, Sanders GD. Efficacy and tolerability of treatments for chronic cough: a systematic review and meta-analysis. Chest. 2013 Dec;144(6):1827–1838.

Published In

Chest

DOI

EISSN

1931-3543

Publication Date

December 2013

Volume

144

Issue

6

Start / End Page

1827 / 1838

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Severity of Illness Index
  • Respiratory System
  • Outcome Assessment, Health Care
  • Humans
  • Cough
  • Chronic Disease
  • Antitussive Agents
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology